Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Moderna Inc
(NQ:
MRNA
)
82.44
+1.40 (+1.73%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Moderna Inc
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
$100 Invested In This Stock 5 Years Ago Would Be Worth $500 Today
August 23, 2024
Via
Benzinga
The Stock Market Isn't Rocking This Month But The S&P 500 Is Headed For Its Best August In 3 Years
August 23, 2024
Kellanova and Fortinet are leading the S&P 500's August performance.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Europe Approves Moderna's RSV Vaccine For Adults 60 And Over
August 23, 2024
Moderna secures European Commission approval for its mRNA RSV vaccine, mRESVIA, to protect adults 60+ from RSV-related respiratory disease. The approval follows positive EMA CHMP opinion, based on...
Via
Benzinga
Nasdaq 100 Slumps 1.6% As Traders Turn Cautious Ahead Of Powell's Jackson Hole Address
August 22, 2024
The Nasdaq 100 fell 1.6% on Thursday as investors awaited Fed Chair Powell's Jackson Hole speech. Private sector data and tech stock declines added to bearish sentiment.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Moderna's Options: A Look at What the Big Money is Thinking
August 21, 2024
Via
Benzinga
Demystifying Moderna: Insights From 11 Analyst Reviews
August 15, 2024
Via
Benzinga
Smart Money Is Betting Big In MRNA Options
August 13, 2024
Via
Benzinga
Market Whales and Their Recent Bets on MRNA Options
August 12, 2024
Via
Benzinga
FDA Approves Updated COVID Vaccines From Pfizer And Moderna, But Leaves Out Novavax's Shot
August 22, 2024
The FDA granted emergency use authorization for updated mRNA COVID-19 vaccines targeting the Omicron KP.2 strain, including new formulas from Moderna and Pfizer/BioNTech. These vaccines, designed to...
Via
Benzinga
Exposures
COVID-19
Product Safety
Stocks Move Lower As Rate Cut Enthusiasm Fades
August 22, 2024
The enthusiasm that followed the release of the Federal Reserve's meeting minutes is already fading.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
S&P 500, Nasdaq 100 Snap 8-Day Winning Streak: What Triggered Wall Street's Setback On Tuesday?
August 20, 2024
S&P 500 ended Tuesday's session with slight declines, halting its best winning streak since May 2024. Here's the latest.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
S&P 500, Nasdaq 100 Extend 8-Session Winning Streak As Wall Street Jitters 'Go Poof': Monday's Key Stock Movers
August 19, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
What the Options Market Tells Us About Moderna
August 07, 2024
Via
Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $6,300 Today
August 05, 2024
Via
Benzinga
Novavax Stock Rocketed This Year, But Challenges Persist. Is It A Buy Or A Sell?
August 19, 2024
Its 12-month relative strength performance is impressive, but Novavax now faces resistance.
Via
Investor's Business Daily
FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch
August 19, 2024
The FDA may approve updated COVID-19 vaccines this week to combat recent strains as the country endures a significant summer outbreak.
Via
Benzinga
Topics
ETFs
Exposures
COVID-19
Product Safety
Pfizer and BioNTech's Combo Shot Missed the Mark. Is It Time to Sell?
August 19, 2024
A clinical-trial failure for Pfizer and BioNTech means Moderna is leading the race to develop a combo shot for the flu and COVID-19.
Via
The Motley Fool
Pfizer, BioNTech's COVID-19/Flu Combo Vaccine Fails To Meet Key Goal In Late-Stage Study
August 16, 2024
Pfizer and BioNTech report Phase 3 results for their combined mRNA vaccine against influenza and COVID-19. The trial met one of two primary immunogenicity objectives. Adjustments are planned to improve...
Via
Benzinga
Exposures
COVID-19
Struggling COVID-19 Vaccines From AstraZeneca, BioNTech/Pfizer, Moderna Cut Incidence Of Arterial Thromboses That Cause Heart Attacks, Strokes, British Study Shows
August 13, 2024
COVID-19 vaccinations could lower the incidence of heart attacks and strokes, according to a new study by UK universities. The research shows a significant reduction in cardiovascular events among...
Via
Benzinga
Exposures
COVID-19
Long Covid Remains Diagnostic Mystery, Diagnosis Remains Elusive; National Institutes of Health-Funded Study Shows
August 13, 2024
A recent NIH study reveals no clear diagnostic test for Long Covid, highlighting ongoing challenges in identifying and treating the condition affecting millions of Americans. Researchers continue to...
Via
Benzinga
Exposures
COVID-19
3 Biotech Stocks Poised for a Comeback After Last Week’s Market Meltdown
August 13, 2024
Investors should closely watch these three biotech stocks as their strong prospects are likely to help the rebound from market volatility.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
August 12, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
August 08, 2024
Via
Benzinga
Expanding the Cloud for AI
August 08, 2024
Amazon, Alphabet, Microsoft, and Meta are all spending a ton of money to build out cloud capabilities to fuel the next phase of AI growth. But the market isn't sold on that spend yet.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
3 Undervalued Stocks With Room to Rally Even Higher
August 05, 2024
The latest market sell-off could be a great time to give the slate of undervalued stocks another look before tech reverses course.
Via
InvestorPlace
Moderna Lost 27% Of Its Value Over Two Days. It Just Crumbled Again.
August 05, 2024
Moderna sustained a rare downgrade on Monday following its guidance cut for the year.
Via
Investor's Business Daily
Home Depot To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Monday
August 05, 2024
Via
Benzinga
BioNTech's Q2 Loss Widens Amid Low Demand For Its Pfizer-Partnered COVID-19 Vaccine, Increases R&D Spending On New Cancer Products
August 05, 2024
BioNTech posted a significant Q2 2024 loss of 807.8 million euros. Sales dropped to 128.7 million euros as the demand for COVID-19 vaccines shifted. R&D expenses rose due to late-stage oncology...
Via
Benzinga
Exposures
COVID-19
MicroStrategy, Intel And Moderna Are Among Top 12 Large Cap Losers Last Week (July 28-August 3): Are The Others In Your Portfolio?
August 04, 2024
12 worst-performing large-cap stocks in the last week. Symbotic, Intel, Snap, Moderna, Mobileye, Pinterest, Arm, Entegris, Atlassian, MicroStrategy, New Oriental, and Western Digital.
Via
Benzinga
Cathie Wood Bought This Stock After Its 27% Drop. Should You?
August 04, 2024
This biotech company's promising pipeline could result in multibillion-dollar revenue.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.